Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT (Unaudited)

v3.20.4
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT (Unaudited) - USD ($)
$ in Thousands
Total
Cumulative Effect Period of Adoption Adjustment
Common Stock
Additional Paid in Capital (Deficit)
Retained Deficit
Retained Deficit
Cumulative Effect Period of Adoption Adjustment
Beginning Balance at Sep. 28, 2019 $ (887,357) $ 12 $ 157 $ (279,848) $ (607,666) $ 12
Beginning Balance, Shares at Sep. 28, 2019     156,500,000      
Equity-based compensation 597     597    
Net loss (26,187)       (26,187)  
Ending Balance at Dec. 28, 2019 (912,935)   $ 157 (279,251) (633,841)  
Ending Balance, Shares at Dec. 28, 2019     156,500,000      
Beginning Balance at Oct. 03, 2020 (826,999)   $ 157 (278,063) (549,093)  
Beginning Balance, Shares at Oct. 03, 2020     156,500,000      
Issuance of shares under stock incentive plans, Shares     118,446      
Issuance of common stock upon initial public offering, net of offering costs 458,686   $ 30 458,656    
Issuance of common stock upon initial public offering, net of offering costs, Shares     30,000,000      
Equity-based compensation 12,160     12,160    
Net loss (30,257)       (30,257)  
Ending Balance at Jan. 02, 2021 $ (386,410)   $ 187 $ 192,753 $ (579,350)  
Ending Balance, Shares at Jan. 02, 2021     186,618,446